Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
- Latest News
- Most Popular
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Top Value Stocks
- RTI: When Will We Finally See a Pullback?
- RTI: When is the Fed's "Taper Telegraph" Coming?
- Insurance Industry Stock Outlook - May 2013
- Top Stocks with Big Potential Catch-Up Moves
- Roundtable Top Picks of the Week
- The Mega-Rally Rolls On
- Biotechnology ETF Investing 101
- AWS 5/22: Will Bernanke Show His Hand?
- PFP 5/22: Singular Stock Focus Continues
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/21/2013
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
TPC Group makes a variety of chemicals for performance, specialty and intermediate markets. Products include synthetic rubber, fuels, lubricant additives, plastics and surfactants.
Revenue Doubles
On Sep 17 TPC Group reported fiscal 2010 fourth-quarter results that included a 104% jump in revenue from the same period last year, to $532 million. Sequentially the top line grew 33%.
Net income more than tripled since last year, to $14.4 million from $4.1 million and up from $7.8 million in the fiscal third quarter. Earnings per share came in at 80 cents, beating the Zacks Consensus Estimate by a quarter.
Estimates Jump
After the earnings release the covering analyst that reports to Zacks upped their full-year estimates substantially. The fiscal 2011 estimate is now $2.25, up from $1.77. Next year's forecast is $2.91, up from $2.17. If TPC Group meets these expectations the annual growth rates will be 108% and 29%.
And a Good Value
Shares of TPCG are trading at just 12 times the forward estimate, thanks to the upward revision. The PEG ratio of 0.4 shows a deep discount on those growth rates.
The price to sales ratio is just 0.29, which is well ahead of its peers that average 0.94.
The Chart
Stocks that shoot up this much, this fast can be tough for investors to buy, fearing they missed the party. But, keep those excellent valuations and growth rates in mind. There is still plenty of upside for this Zacks #1 Rank (Strong Buy)
Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service